{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:31:03Z","timestamp":1787495463547,"version":"build-2736575974"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1248\/bpb.b20-00904","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T18:10:08Z","timestamp":1619806208000},"page":"627-634","source":"Crossref","is-referenced-by-count":11,"title":["Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database"],"prefix":"10.1248","volume":"44","author":[{"given":"Takashi","family":"Omoto","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Asaka","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital"},{"name":"Department of Clinical Pharmaceutics, School of Pharmacy, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Sakai","sequence":"additional","affiliation":[{"name":"Drug Informatics, Faculty of Pharmacy, Meijo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Fukui Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital"},{"name":"Department of Clinical Pharmaceutics, School of Pharmacy, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. <i>Ann. Oncol.<\/i>, <b>18<\/b>, 1437\u20131449 (2007)."},{"key":"2","unstructured":"2) Stjernsw\u00e4rd J. WHO cancer pain relief programme. <i>Cancer Surv.<\/i>, <b>7<\/b>, 195\u2013208 (1988)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Stjernsw\u00e4rd J, Colleau SM, Ventafridda V. The World Health Organization cancer pain and palliative care program. past, present, and future. <i>J. Pain Symptom Manage.<\/i>, <b>12<\/b>, 65\u201372 (1996).","DOI":"10.1016\/0885-3924(96)00109-1"},{"key":"4","unstructured":"4) McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. <i>J. Pain<\/i>, <b>4<\/b>, 231\u2013256 (2003)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lim KH, Nguyen NN, Qian Y, Williams JL, Lui DD, Bruera E, Yennurajalingam S. Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care. <i>J. Palliat. Med.<\/i>, <b>21<\/b>, 1698\u20131704 (2018).","DOI":"10.1089\/jpm.2018.0169"},{"key":"6","unstructured":"6) Mannesse CK, Derkx FH, de Ridder MA, Man in\u2019t Veld AJ, van der Cammen TJ. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. <i>BMJ<\/i>, <b>315<\/b>, 1057\u20131058 (1997)."},{"key":"7","unstructured":"7) Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. <i>JAMA<\/i>, <b>279<\/b>, 1200\u20131205 (1998)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Akishita M, Teramoto S, Arai H, Arai H, Mizukami K, Morimoto S, Toba K. Incidence of adverse drug reactions in geriatric wards of university hospitals. <i>Nippon Ronen Igakkai Zasshi<\/i>, <b>41<\/b>, 303\u2013306 (2004).","DOI":"10.3143\/geriatrics.41.303"},{"key":"9","unstructured":"9) O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. <i>Age Ageing<\/i>, <b>44<\/b>, 213\u2013218 (2015)."},{"key":"10","unstructured":"10) Carri\u00e8re I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, Ancelin ML. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. <i>Arch. Intern. Med.<\/i>, <b>169<\/b>, 1317\u20131324 (2009)."},{"key":"11","unstructured":"11) Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. <i>Drugs Aging<\/i>, <b>29<\/b>, 359\u2013376 (2012)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ando G, Taguchi K, Enoki Y, Yokoyama Y, Kizu J, Matsumoto K. Evaluation of the expression time of ganciclovir-induced adverse events using JADER and FAERS. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 1799\u20131804 (2019).","DOI":"10.1248\/bpb.b19-00156"},{"key":"13","unstructured":"13) Ishida T, Kawada K, Morisawa S, Jobu K, Morita Y, Miyamura M. Risk factors for pseudoaldosteronism with Yokukansan use: analysis using the Japanese Adverse Drug Report (JADER) database. <i>Biol. Pharm. Bull.<\/i>, <b>43<\/b>, 1570\u20131576 (2020)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nakao S, Hatahira H, Sasaoka S, Hasegawa S, Motooka Y, Ueda N, Abe J, Fukuda A, Naganuma M, Kanoh H, Seishima M, Ishiguro M, Kinosada Y, Nakamura M. Evaluation of drug-induced photosensitivity using the Japanese Adverse Drug Event Report (JADER) database. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 2158\u20132165 (2017).","DOI":"10.1248\/bpb.b17-00561"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H. Analyses of respiratory depression associated with opioids in cancer patients based on the Japanese Adverse Drug Event Report database. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 1185\u20131191 (2019).","DOI":"10.1248\/bpb.b19-00105"},{"key":"16","unstructured":"16) Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side effects of opioids during short-term administration: effect of age, gender, and race. <i>Clin. Pharmacol. Ther.<\/i>, <b>74<\/b>, 102\u2013112 (2003)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Vorsanger G, Xiang J, Jordan D, Farrell J. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. <i>Clin. Ther.<\/i>, <b>29<\/b> (Suppl.), 2520\u20132535 (2007).","DOI":"10.1016\/j.clinthera.2007.12.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Noguchi Y, Ueno A, Katsuno H, Otsubo M, Yoshida A, Kanematsu Y, Sugita I, Tachi T, Tsuchiya T, Teramachi H. Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database. <i>J. Pharm. Health Care Sci.<\/i>, <b>4<\/b>, 10 (2018).","DOI":"10.1186\/s40780-018-0106-2"},{"key":"19","unstructured":"19) Noguchi Y, Hayashi Y, Yoshida A, Sugita I, Esaki H, Saito K, Usui K, Kato M, Tachi T, Teramachi H. Search for oral medicine that might exacerbate the prognosis of adverse drug events in elderly patients. <i>Jpn. J. Drug Inform.<\/i>, <b>18<\/b>, 277\u2013283 (2016)."},{"key":"20","unstructured":"20) European Medicines Agency. \u201cScreening for adverse reactions in EudraVigilance.\u201d: \u2039https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf\u203a, accessed 25 July, 2019."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. <i>Ther. Adv. Drug Saf.<\/i>, <b>7<\/b>, 11\u201322 (2016).","DOI":"10.1177\/2042098615615472"},{"key":"22","unstructured":"22) Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, Fukui T, Saito M, Hiraide A, Bates DW. Incidence of adverse drug events and medication errors in Japan: the JADE study. <i>J. Gen. Intern. Med.<\/i>, <b>26<\/b>, 148\u2013153 (2011)."},{"key":"23","unstructured":"23) Pedr\u00f3s C, Formiga F, Corbella X, Arnau JM. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>72<\/b>, 219\u2013226 (2016)."},{"key":"24","unstructured":"24) Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. <i>Br. J. Clin. Pharmacol.<\/i>, <b>57<\/b>, 6\u201314 (2004)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Chisaki Y, Aoji S, Yano Y. Analysis of adverse drug reaction risk in elderly patients using the Japanese Adverse Drug Event Report (JADER) database. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 824\u2013829 (2017).","DOI":"10.1248\/bpb.b16-00930"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hatahira H, Hasegawa S, Sasaoka S, Kato Y, Abe J, Motooka Y, Fukuda A, Naganuma M, Nakao S, Mukai R, Shimada K, Hirade K, Kato T, Nakamura M. Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database. <i>J Pharm Health Care Sci<\/i>, <b>4<\/b>, 32 (2018).","DOI":"10.1186\/s40780-018-0129-8"},{"key":"27","unstructured":"27) Andreaggi CA, Novak EA, Mirabile ME, Sampathkumar S, Gray MP, He M, Kane-Gill SL. Safety concerns reported by consumers, manufacturers and healthcare professionals: a detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years. <i>Pharmacoepidemiol. Drug Saf.<\/i>, <b>29<\/b>, 1627\u20131635 (2020)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Fiske A, Wetherell JL, Gatz M. Depression in older adults. <i>Annu. Rev. Clin. Psychol.<\/i>, <b>5<\/b>, 363\u2013389 (2009).","DOI":"10.1146\/annurev.clinpsy.032408.153621"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. <i>Pain Med.<\/i>, <b>15<\/b>, 1911\u20131929 (2014).","DOI":"10.1111\/pme.12480"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, Sch\u00fcttler J. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. <i>Clin. Pharmacol. Ther.<\/i>, <b>65<\/b>, 630\u2013639 (1999).","DOI":"10.1016\/S0009-9236(99)90084-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Naples JG, Gellad WF, Hanlon JT. The role of opioid analgesics in geriatric pain management. <i>Clin. Geriatr. Med.<\/i>, <b>32<\/b>, 725\u2013735 (2016).","DOI":"10.1016\/j.cger.2016.06.006"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Bentley JB, Borel JD, Nenad RE Jr, Gillespie TJ. Age and fentanyl pharmacokinetics. <i>Anesth. Analg.<\/i>, <b>61<\/b>, 968\u2013971 (1982).","DOI":"10.1213\/00000539-198212000-00002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Vella-Brincat J, Macleod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. <i>J. Pain Palliat. Care Pharmacother.<\/i>, <b>21<\/b>, 15\u201325 (2007).","DOI":"10.1080\/J354v21n01_05"},{"key":"34","unstructured":"34) Winegarden J, Carr DB, Bradshaw YS. Intravenous ketamine for rapid opioid dose reduction, reversal of opioid-induced neurotoxicity, and pain control in terminal care: case report and literature review. <i>Pain Med.<\/i>, <b>17<\/b>, 644\u2013649 (2016)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Hara A, Matsumoto K, Yokoyama Y, Kizu J. Factorial analysis of hepatitis B virus reactivation-induced hepatitis B using JADER. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 782\u2013788 (2017).","DOI":"10.1248\/bpb.b16-00765"},{"key":"36","unstructured":"36) Wisniewski AFZ, Bate A, Bousquet C, Brueckner A, Candore G, Juhlin K, Macia-Martinez MA, Manlik K, Quarcoo N, Seabroke S, Slattery J, Southworth H, Thakrar B, Tregunno P, Van Holle L, Kayser M, Nore\u2019n GN. Good signal detection practices: evidence from IMI PROTECT. <i>Drug Saf.<\/i>, <b>39<\/b>, 469\u2013490 (2016)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) William B, Yesne A. Evidence-based treatment of delirium in patients with cancer. <i>J. Clin. Oncol.<\/i>, <b>30<\/b>, 1206\u20131214 (2012).","DOI":"10.1200\/JCO.2011.39.8784"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/5\/44_b20-00904\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T23:33:10Z","timestamp":1619825590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/5\/44_b20-00904\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00904","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}